Press Release Press Release List

First Impact Factor for : Endocrine, Metabolic & Immune Disorders - Drug Targets PRESS RELEASE DATE : 23-June-2016

Dubai, UAE, June 23, 2016: Endocrine, Metabolic & Immune Disorders - Drug Targets has obtained its first Impact Factor 1.987. The Impact Factor ranking has been awarded by Journal Citation ReportsĀ®, which are annually published by the Institute of Scientific Information, a division of Thomson Reuters. Its purpose is to offer a systematic means to critically evaluate the world's leading journals, with quantifiable, statistical information based on citation data.

Endocrine, Metabolic & Immune Disorders - Drug Targets publishes timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. For more information, please visit:

Ā© 2024 Bentham Science Publishers | Privacy Policy